Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer

Abstract Background Two prospective phase II trials were designed to assess the efficacy and safety of image-guided proton therapy (IGPT) for either medically inoperable or operable stage I non-small cell lung cancer (NSCLC). The present study reports the interim results of these trials. Methods Fif...

Full description

Bibliographic Details
Main Authors: Koichiro Nakajima, Hiromitsu Iwata, Hiroyuki Ogino, Yukiko Hattori, Shingo Hashimoto, Toshiyuki Toshito, Kensuke Hayashi, Kenji Akita, Fumiya Baba, Katsumi Nakamae, Jun-etsu Mizoe, Yuta Shibamoto
Format: Article
Language:English
Published: BMC 2018-10-01
Series:Radiation Oncology
Subjects:
Stage I non-small cell lung cancer
Proton therapy
Image-guided proton therapy
Fiducial metallic marker
Respiratory gating system
Online Access:http://link.springer.com/article/10.1186/s13014-018-1144-5

Internet

http://link.springer.com/article/10.1186/s13014-018-1144-5

Similar Items